WOCKPHARMA — Wockhardt Balance Sheet
0.000.00%
- IN₹292.23bn
- IN₹309.35bn
- IN₹30.12bn
Annual balance sheet for Wockhardt, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2,326 | 3,810 | 900 | 5,050 | 6,130 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 9,896 | 11,970 | 10,640 | 8,570 | 7,150 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 24,244 | 25,890 | 22,080 | 21,840 | 25,690 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 29,143 | 28,600 | 24,360 | 23,090 | 22,310 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 77,727 | 82,430 | 76,830 | 76,490 | 81,350 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 31,182 | 32,070 | 34,350 | 27,910 | 20,420 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 43,959 | 43,940 | 43,290 | 42,900 | 37,820 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 33,768 | 38,490 | 33,540 | 33,590 | 43,530 |
Total Liabilities & Shareholders' Equity | 77,727 | 82,430 | 76,830 | 76,490 | 81,350 |
Total Common Shares Outstanding |